bmy 28142 , a new broad-spectrum semisynthetic cephalosporin , was evaluated in vitro and in vivo in comparison with ceftazidime , cefotaxime , moxalactam , and cefoperazone .
C3536856
cephalosporin
C0007559
ceftazidime